메뉴 건너뛰기
Journal of Reproductive Medicine for the Obstetrician and Gynecologist
Volumn 54, Issue 5, 2009, Pages 288-290
A conservative approach in persistent low-level elevation of serum β-human chorionic gonadotropin following chemotherapy for gestational trophoblastic neoplasia
Author keywords

human chorionic gonadotropin; Gestational trophoblastic disease; Gestational trophoblastic neoplasia
Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; DACTINOMYCIN; ETOPOSIDE; METHOTREXATE; ANTINEOPLASTIC AGENT;
EID: 67649934352     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)
References (7)
  • 1
    • 10644245919 scopus 로고    scopus 로고
    • Gestational trophoblastic neoplasia: FIGO 2000 staging and classification
    • Ngan HY, Bender H, Benedet JL, et al: Gestational trophoblastic neoplasia: FIGO 2000 staging and classification. Int J Gynaecol Obstet Suppl 1 2003;83:175-177
    • (2003) Int J Gynaecol Obstet , vol.83 , Issue.SUPPL. 1 , pp. 175-177
    • Ngan, H.Y.1    Bender, H.2    Benedet, J.L.3
  • 2
    • 0030942621 scopus 로고    scopus 로고
    • Gestational trophoblastic diseases and their treatment
    • Fisher PM, Hancock BW: Gestational trophoblastic diseases and their treatment. Cancer Treat Rev 1997;23;1-16
    • (1997) Cancer Treat Rev , vol.23 , pp. 1-16
    • Fisher, P.M.1    Hancock, B.W.2
  • 3
    • 0034073930 scopus 로고    scopus 로고
    • Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy
    • Gillespie AM Kumar S, Hancock BW: Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy Br J Cancer 2000;82:1393-1395
    • (2000) Br J Cancer , vol.82 , pp. 1393-1395
    • Gillespie, A.M.1    Kumar, S.2    Hancock, B.W.3
  • 4
    • 33745894019 scopus 로고    scopus 로고
    • Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia
    • Cole LA, Butler SA, Khanlian SA, et al: Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecol Oncol 2006;102:151-159
    • (2006) Gynecol Oncol , vol.102 , pp. 151-159
    • Cole, L.A.1    Butler, S.A.2    Khanlian, S.A.3
  • 5
    • 33750220222 scopus 로고    scopus 로고
    • Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotrophin
    • Khanlian SA, Cole LA: Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotrophin. J Reprod Med 2006;51:812-818
    • (2006) J Reprod Med , vol.51 , pp. 812-818
    • Khanlian, S.A.1    Cole, L.A.2
  • 6
    • 2942689274 scopus 로고    scopus 로고
    • Inappropriate management of women with persistent low beta-hCG results
    • Cole LA, Khanlian SA: Inappropriate management of women with persistent low beta-hCG results. J Reprod Med 2004;48: 423-432
    • (2004) J Reprod Med , vol.48 , pp. 423-432
    • Cole, L.A.1    Khanlian, S.A.2
  • 7
    • 34250217792 scopus 로고    scopus 로고
    • Management and outcome of healthy women with a persistently elevated beta-hCG
    • Palmieri C, Dhillon T, Fisher RA, et al: Management and outcome of healthy women with a persistently elevated beta-hCG. Gynecol Oncol 2007;106:35-43
    • (2007) Gynecol Oncol , vol.106 , pp. 35-43
    • Palmieri, C.1    Dhillon, T.2    Fisher, R.A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.